Avalo Therapeutics, Inc. Common Stock (AVTX)

Typically moves ±4.96% on earnings
EARNINGS ANALYTICS
search

Avalo Therapeutics, Inc. Common Stock (AVTX) has a 20-report earnings history dating back to Aug 02, 2021. Its average absolute post-earnings move is ±4.96%, and 35.0% of those reactions were positive. Its largest post-earnings gain was +9.59% (Aug 04, 2022) and its largest decline was -14.64% (May 05, 2022).

Earnings reactions

How AVTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±4.96%

Positive %

35.0%

Negative %

65.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 13, 2026 ☀ PRE -0.63% open_in_new
May 07, 2026 ☽ POST -6.23% open_in_new
Mar 23, 2026 ☀ PRE +0.67% open_in_new
Nov 06, 2025 ☀ PRE -6.16% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.96%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 13 →
13
Funds holding
$21234906
Total value held
Buying
9 added · 4 reduced
Bank Of America Corp /De/
$9599990 +3.48%
Blackrock, Inc.
$4883335 +12.95%
Morgan Stanley
$2409583 -39.08%
State Street Corp
$1069794 -9.59%
Goldman Sachs Group Inc
$897383 -7.97%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
S-3 20260717 open_in_new SEC.gov
SCHEDULE 13G/A 20260706 open_in_new SEC.gov
4 20260702 open_in_new SEC.gov
4 20260702 open_in_new SEC.gov
4 20260702 open_in_new SEC.gov
4 20260702 open_in_new SEC.gov
3 20260625 open_in_new SEC.gov
4 20260625 open_in_new SEC.gov
4 20260625 open_in_new SEC.gov
8-K 20260623 open_in_new SEC.gov

Frequently asked about AVTX earnings

How much does AVTX stock move after earnings? expand_more

Over 20 reports, AVTX has moved an average of ±4.96% the session after earnings, closing higher 35.0% of the time.

What was AVTX's biggest post-earnings move? expand_more

AVTX's largest post-earnings gain on record was +9.59% on Aug 04, 2022, and its largest decline was -14.64% on May 05, 2022.

Where can I find Avalo Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Avalo Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers